PHARMACOKINETIC INTERACTION BETWEEN ROSUVASTATIN AND FENOFIBRATE IN HEALTHY VOLUNTEERS.

被引:0
|
作者
Yi, S. [1 ]
Kim, M. [2 ]
Han, S. [3 ]
Park, M. [1 ]
机构
[1] Dong A Univ, Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Pusan, South Korea
[2] Dong A Univ, Coll Med, Dept Cardiol, Pusan, South Korea
[3] Dong A Univ, Coll Med, Dept Family Med, Pusan, South Korea
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PII-010
引用
收藏
页码:S62 / S62
页数:1
相关论文
共 50 条
  • [1] Pharmacokinetic study on the interaction between cabergoline and clarithromycin in healthy volunteers.
    Nomura, T
    Zhang, J
    Nakatsuka, A
    Nomoto, M
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 74P - 74P
  • [2] ASSESSMENT OF THE PHARMACOKINETIC INTERACTION BETWEEN FIMASARTAN AND LINAGLIPTIN IN HEALTHY VOLUNTEERS.
    Seong, S.
    Kang, W.
    Ohk, B.
    Kim, B.
    Gwon, M. -R.
    Cho, S.
    Lee, H.
    Yoon, Y. -R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S70 - S70
  • [3] Lack of pharmacokinetic interaction between morphine and dextromethorphan in healthy volunteers.
    Caruso, FS
    Johnson, DA
    Noonan, PK
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 122 - 122
  • [4] Pharmacokinetic Drug Interaction Between Rosuvastatin and Tanjin in Healthy Volunteers and Rats
    Yang, Jie
    Hasegawa, Junichi
    Endo, Yusuke
    Iitsuka, Kazuhiko
    Yamamoto, Miwa
    Matsuda, Akiko
    [J]. YONAGO ACTA MEDICA, 2019, 62 (01) : 77 - 84
  • [5] Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers
    Pan, WJ
    Gustavson, LE
    Achari, R
    Rieser, MJ
    Ye, X
    Gutterman, C
    Wallin, BA
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (03): : 316 - 323
  • [6] PHARMACOKINETIC DRUG INTERACTION BETWEEN TELMISARTAN/AMLODIPINE AND HYDROCHLOROTHIAZIDE IN HEALTHY MALE VOLUNTEERS.
    Kim, M. -G.
    Lee, S.
    Kim, Y.
    Kim, S. -Y.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S73 - S74
  • [7] Pharmacokinetic interactions between udenafil and ketoconazole in healthy volunteers.
    Kim, J. W.
    Kim, J. R.
    Lim, K. S.
    Kim, B. H.
    Kim, M. G.
    Chung, Y. J.
    Kim, T. E.
    Cho, J. Y.
    Yu, K. S.
    Jang, I. J.
    Shin, S. G.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S114 - S115
  • [8] No interaction between nebivolol and digoxin in healthy volunteers.
    Lawrence, TE
    Liu, S
    Fisher, JW
    Vukic-Bugarski, T
    Donnelly, CM
    Huang, MY
    Rackley, RJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P76 - P76
  • [9] PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND MEITORMIN AT STEADY-STATE IN HEALTHY KOREAN VOLUNTEERS.
    Choi, H.
    Kim, D.
    Seo, J.
    Ghim, J.
    Koo, Y.
    Shin, J.
    Kim, E.
    Kim, E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S40 - S40
  • [10] Pharmacokinetic drug interaction study using fimasartan and rosuvastatin in healthy volunteers
    Kang, Woo Youl
    Kim, Eun Hee
    Seong, Sook Jin
    Gwon, Mi-Ri
    Yang, Dong Heon
    Kim, Hyun-Ju
    Lim, Mi-Sun
    Lee, Hae Won
    Yoon, Young-Ran
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (12) : 992 - 1003